Back Back
Cell No. : Cell Name
RCB2204 : TFS-4  update : 2023/10/16
CommentHybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
Comment from the depositor
Terms and conditions1) The RECIPIENT must contact theDEPOSITOR in the case of application for any patents or commercial usebased on the results from the use of the BIOLOGICAL RESOURSE.
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (
Basic information Depositor Okabe, Tetsuro
Originator Okabe, Tetsuro
Year of deposit 2005
Animal _mouse x mouse < Hybrid
Tissue hybridoma
Classification hybrid cells
Lifespan infinite
Morphology lymphocyte-like
Cellosaurus(Expasy) CVCL_J859
hybridoma Fusion_cell_1 name P3U1
Fusion_cell_1 strain mouse
Fusion_cell_2 name spleen cell
Fusion_cell_2 strain mouse, BALB/c
Fusion method PEG
Antibody name TFS-4
Subclass IgG1
Immunogen Human Small cell lung carcinoma
Antigen_name TFS-4
Antigen_m.w. 124000
Antigen_character Surface antigen of small cell carcinoma
Antigen_positive Lung cancer, Neuroblastoma
Antigen_negative Stomach cancer, Pancreas cancer, Uterus cancer
deposit info
lot info
Medium Medium List
Culture type Suspension cells
Culture medium RPMI1640 + 10% FBS
Antibiotics Free
Passage method dilution
Culture information Passage ratio 1 : 10 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
Antibody subclass IgG1
Reference information Reference 0
User's Publication 0

To topTop

To topTop
User's Publication

Back Back Return Top Page